POT1 and glioma: The detection of germline variants in genes involved in telomere regulation, such as RTEL1, POT1, TERC, and also in the telomerase reverse transcriptase promoter (TERT), has been used to identify increased risk of glioma and melanoma, as well as lung, bladder and pancreas cancer [16].